MAPT and Alzheimer disease: The risk effects of APOE4 in AD were linked to ApoE’s pleiotropic functions that lead to reduced cholesterol transport, less efficient Aβ clearance and more aggregation, triggering neurotoxicity through Tau phosphorylation, increased brain neuronal activity and atrophy, reduced synaptic plasticity, and greater neuroinflammation.